Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age
- PMID: 33765428
- PMCID: PMC8286465
- DOI: 10.1016/j.neurobiolaging.2021.01.030
Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age
Abstract
This study examined the effect of neurodegeneration, and its interaction with Alzheimer's disease (AD) cerebrospinal fluid biomarkers, on longitudinal verbal learning and memory performance in cognitively unimpaired (CU) late middle-aged adults. Three hundred and forty-two CU adults (cognitive baseline mean age = 58.4), with cerebrospinal fluid and structural MRI, completed 2-10 (median = 5) cognitive assessments. Learning and memory were assessed using the Rey Auditory Verbal Learning Test (RAVLT). We used sequential comparison of nested linear mixed effects models to analyze the data. Model selection preserved a significant ptau181/Aβ42 × global atrophy × age interaction; individuals with less global atrophy and lower ptau181/Aβ42 levels had less learning and delayed recall decline than individuals with more global atrophy and/or higher levels of ptau181/Aβ42. The hippocampal volume × age × ptau181/Aβ42 interaction was not significant. Findings suggest that in a sample of CU late middle-aged adults, individuals with AD biomarkers, global atrophy, or both evidence greater verbal learning and memory decline than individuals without either risk factor.
Keywords: Cerebrospinal fluid biomarkers; Global atrophy; Hippocampus; Preclinical Alzheimer's disease; Verbal learning; Verbal memory.
Published by Elsevier Inc.
Figures


Similar articles
-
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018. Neuroimage Clin. 2018. PMID: 30023169 Free PMC article.
-
Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.J Alzheimers Dis. 2017;60(3):1119-1128. doi: 10.3233/JAD-160766. J Alzheimers Dis. 2017. PMID: 28984585
-
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713. J Alzheimers Dis. 2018. PMID: 30412495
-
Cognitively normal women with Alzheimer's disease proteinopathy show relative preservation of memory but not of hippocampal volume.Alzheimers Res Ther. 2019 Dec 26;11(1):109. doi: 10.1186/s13195-019-0565-1. Alzheimers Res Ther. 2019. PMID: 31878968 Free PMC article.
-
Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment.JAMA Netw Open. 2019 Dec 2;2(12):e1917363. doi: 10.1001/jamanetworkopen.2019.17363. JAMA Netw Open. 2019. PMID: 31834392 Free PMC article.
Cited by
-
Lower Preoperative Verbal Memory Performance Is Associated with Delirium after Coronary Artery Bypass Graft Surgery: A Prospective Cohort Study.Arch Clin Neuropsychol. 2023 Jan 21;38(1):49-56. doi: 10.1093/arclin/acac064. Arch Clin Neuropsychol. 2023. PMID: 35915987 Free PMC article.
-
Abdominal aortic calcification on lateral spine images captured during bone density testing and late-life dementia risk in older women: A prospective cohort study.Lancet Reg Health West Pac. 2022 Jun 26;26:100502. doi: 10.1016/j.lanwpc.2022.100502. eCollection 2022 Sep. Lancet Reg Health West Pac. 2022. PMID: 36213133 Free PMC article.
-
Performance change while learning novel cognitive tasks as a potential identifier of preclinical Alzheimer's disease.J Alzheimers Dis Rep. 2025 Jul 15;9:25424823251356597. doi: 10.1177/25424823251356597. eCollection 2025 Jan-Dec. J Alzheimers Dis Rep. 2025. PMID: 40673133 Free PMC article.
-
Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort.Alzheimers Dement. 2023 Jul;19(7):3108-3118. doi: 10.1002/alz.12920. Epub 2023 Feb 1. Alzheimers Dement. 2023. PMID: 36723444 Free PMC article.
-
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors.Brain Commun. 2023 Dec 3;5(6):fcad333. doi: 10.1093/braincomms/fcad333. eCollection 2023. Brain Commun. 2023. PMID: 38107504 Free PMC article.
References
-
- Akaike H. (1987). Factor analysis and AIC. In Selected Papers of Hirotugu Akaike (pp. 371–386). Springer.
-
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, … Petersen RC (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270–279. - PMC - PubMed
-
- Allison SL, Koscik RL, Cary P, Jonaitis EM, Chin N, Rowley HA, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Bendlin BB, & Johnson SC (2019). Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer’s disease spectrum. NeuroImage: Clinical, 23, 101895. - PMC - PubMed
-
- Bäckman L, Jones S, Berger A-K, Laukka EJ, & Small BJ (2005). Cognitive impairment in preclinical Alzheimer’s disease: A meta-analysis. Neuropsychology, 19(4), 520. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical